Menta Capital’s Impax Laboratories, Inc. IPXL Stock Holding History

Menta Capital’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-60,385	Closed	-$1M	–	832
2017 Q4	$1M	Buy	+60,385	New	+$1.11M	0.2%	188
2017 Q1	–	Sell	-58,200	Closed	-$771K	–	1076
2016 Q4	$771K	Buy	+58,200	New	+$995K	0.06%	508
2015 Q3	–	Sell	-5,700	Closed	-$262K	–	882
2015 Q2	$262K	Sell	5,700 -1,340	-19%	-$63.6K	0.04%	553
2015 Q1	$330K	Buy	+7,040	New	+$280K	0.04%	544
2014 Q3	–	Sell	-7,100	Closed	-$213K	–	717
2014 Q2	$213K	Buy	+7,100	New	+$192K	0.04%	456

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Menta Capital's IPXL Position: Q1 2018 in Review

Menta Capital sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 60,385 shares — an estimated $1M sold.

Menta Capital first reported a position in IPXL in Q2 2014 and held it in 5 quarters. The position peaked at $1M in Q4 2017. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

Menta Capital reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
Menta Capital sold 60,385 Impax Laboratories, Inc. shares in Q1 2018, an estimated $1M.
Menta Capital first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 5 quarters.
Menta Capital's Impax Laboratories, Inc. position peaked at $1M in Q4 2017.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Menta Capital's 13F filing for Q1 2018, filed 15 May 2018.